We are live on ! Find out more
KBIO

KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO

Delisted

KBIO was delisted on the 16th of December, 2015.

Back to rankings

39 hedge funds and large institutions have $69.9M invested in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in 2013 Q2 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+39
Holders Change %
–
% of All Funds
1.27%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
39
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$57K +$56.8K +1,253 New
Deutsche Bank
27
Deutsche Bank
Germany
$44K +$45.3K +998 New
TA
28
Teachers Advisors
New York
$42K +$41.7K +919 New
Barclays
29
Barclays
United Kingdom
$37K +$37K +816 New
NFA
30
Nationwide Fund Advisors
Ohio
$36K +$36.5K +804 New
AIG
31
American International Group
New York
$34.1K +$34.1K +753 New
SO
32
STRS Ohio
Ohio
$25K +$25.3K +559 New
U
33
UBS
Switzerland
$6K +$5.89K +130 New
Bank of America
34
Bank of America
North Carolina
$5K +$4.94K +109 New
AllianceBernstein
35
AllianceBernstein
Tennessee
$3K +$2.54K +56 New
BJ
36
BlackRock Japan
Japan
$3K +$2.9K +64 New
Ameriprise
37
Ameriprise
Minnesota
$3K +$3.08K +68 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$2K +$2.27K +50 New
Citigroup
39
Citigroup
New York
– +$45 +1 New
1
2

KBIO Hedge Fund Activity: Q2 2013 in Review

39 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) for Q2 2013, worth a combined $69.9M.

Buyers outnumbered sellers: 39 funds opened new KBIO positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.

  • 39 institutional investors held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $69.9M of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) stock for Q2 2013.
  • 39 funds opened new KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) positions in Q2 2013 and 0 closed out, a net change of +39 holders.

Based on aggregated 13F filings for Q2 2013.